AI주식인사이트AI Stock Insight
B

국제약품

002720KOSPI의약품 제조업

55.8 / 100

Reference Date: 2026-06-10

Financial Score21.5 / 40
News Sentiment21.3 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE significantly exceeds the industry average but the high debt ratio poses financial risk. Plunged 26.1% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Korea Pharmaceutical Co., Ltd. is a company engaged in the manufacture and sale of specialty and general pharmaceuticals, including Quron Eye Drops and Colensina Soft Capsules. With headquarters in Seongnam and manufacturing/R&D facilities in Ansan, the company achieved a 12.2% increase in consolidated sales to 175,496 million won in fiscal year 2025, while conducting 5 ongoing drug development projects.

Number of Employees

272people

Average Salary

68.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
11.86Industry Average 11.935.0Point

In line with industry avg

PBR
0.72Industry Average 0.894.0Point

In line with industry avg

ROE
6.09Industry Average 4.015.5Point

1.5x industry avg (good)

Debt Ratio
23.09Industry Average 12.430.5Point

1.9x industry avg (risky)

Trend 2023~20256.5 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲13.9% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲214.6% (2-year basis)

ROE Trend
1.0 / 4

Avg ROE 0.5% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 3,320Won52-week high 5,23052-week low 3,320
1-month return0.0Point

1m -26.06% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

7 totalPositive 0Neutral 7Negative 0
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-05
  • Neutral기업지배구조보고서공시2026-06-01
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-29
  • Neutral주식등의대량보유상황보고서(일반)2026-05-29
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-27